Dr. Power's research focuses on the implementation of evidence-based interventions for children with attention-deficit/hyperactivity disorder (ADHD) in community settings, including schools and primary care practices. The emphasis of his work is on developing the capacity of professionals in the community to provide evidence-based care for children and adolescents with attention, behavior, and emotional difficulties.
Dr. Hakonarson is director of the Center for Applied Genomics and professor of Pediatrics at the Perelman School of Medicine, University of Pennsylvania. He leads a $40 million commitment from Children’s Hospital of Philadelphia to genomically characterize approximately 100,000 children, an initiative that has gained nationwide attention in the Wall Street Journal, New York Times, Time Magazine, Nature, and Science.
Dr. Guevara is the principal investigator on research grants evaluating health inequities in early childhood development and behavioral problems. He utilizes community-based participatory clinical trials involving parent advocacy groups, community organizations, and government agencies to test the effects of psychosocial interventions designed to provide parents with resources and tools to improve the care of their children.
Dr. Stephenson is an attending pediatric neurologist and medical director of Operations and Outreach for the Division of Neurology at CHOP. She has special interest in neurobehavioral and neurodevelopmental disorders including ADHD, autism, Tourette syndrome, learning disabilities, and developmental delay.
Dr. Shults works to develop statistical methods for longitudinal data that include semi-parametric approaches to account for subject/cluster level associations and maximum likelihood-based approaches for simulation and analysis of discrete longitudinal outcomes that may have overdispersion.